Systemic chemotherapy for Helicobacter pylori eradication?
作者信息
Islam S, McLean A J
出版信息
Gut. 1990 Dec;31(12):1421-2. doi: 10.1136/gut.31.12.1421-b.
Abstract
摘要
相似文献
1
Systemic chemotherapy for Helicobacter pylori eradication?用于根除幽门螺杆菌的全身化疗？
Gut. 1990 Dec;31(12):1421-2. doi: 10.1136/gut.31.12.1421-b.
2
[Oral triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease].
Med Klin (Munich). 1993 May 15;88(5):297-9.
3
Cure of Helicobacter pylori: a hidden curse?幽门螺杆菌的治愈：一种隐藏的祸根？
Am J Gastroenterol. 1997 Dec;92(12):2313-4.
4
The effect of intragastric acidity on Helicobacter pylori eradication with bismuth-metronidazole-amoxicillin.胃内酸度对铋剂-甲硝唑-阿莫西林根除幽门螺杆菌的影响。
Hepatogastroenterology. 1999 Jul-Aug;46(28):2713-7.
5
Omeprazole/amoxicillin versus ranitidine/triple therapy for duodenal ulcer: when is the "same" the same?奥美拉唑/阿莫西林与雷尼替丁/三联疗法治疗十二指肠溃疡：何时“相同”才是相同？
Am J Gastroenterol. 1994 Jun;89(6):947-8.
6
Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.甲硝唑+四环素+枸橼酸铋钾与奥美拉唑+阿莫西林+枸橼酸铋钾治疗幽门螺杆菌相关性胃炎和消化性溃疡疾病的药理作用比较
Eur J Gastroenterol Hepatol. 1994 Dec;6 Suppl 1:S103-7.
7
Helicobacter pylori: fact or fiction?
Scand J Gastroenterol Suppl. 1990;175:159-65. doi: 10.3109/00365529009093139.
8
9
[Eradication of Helicobacter pylori in patients with recurrent abdominal pain using a triple drug treatment].[采用三联药物疗法根除复发性腹痛患者的幽门螺杆菌]
Rev Gastroenterol Mex. 1996 Oct-Dec;61(4):310-3.
10
[Classic triple therapy for Helicobacter pylori infection].
Nihon Rinsho. 2002 Feb;60 Suppl 2:420-2.
本文引用的文献
1
Microbes, peptic ulcer, and relapse rates with different drugs.
Lancet. 1984 Sep 1;2(8401):525-6. doi: 10.1016/s0140-6736(84)92607-2.
2
Prevalence of Campylobacter pylori and association with antral mucosal histology in subjects with and without upper gastrointestinal symptoms.有和无上消化道症状的受试者中幽门螺杆菌的患病率及其与胃窦黏膜组织学的关联
Dig Dis Sci. 1988 Jun;33(6):649-53. doi: 10.1007/BF01540425.
3
Identification of Campylobacter pyloridis isolates by restriction endonuclease DNA analysis.通过限制性内切酶DNA分析鉴定幽门弯曲菌分离株。
J Clin Microbiol. 1986 Sep;24(3):414-7. doi: 10.1128/jcm.24.3.414-417.1986.
4
Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori.幽门螺杆菌根除后十二指肠溃疡复发的前瞻性双盲试验
Lancet. 1988;2(8626-8627):1437-42. doi: 10.1016/s0140-6736(88)90929-4.
5
Pathogenicity of Campylobacter pylori in the upper gastrointestinal tract--implications for modern therapy.幽门螺杆菌在上消化道中的致病性——对现代治疗的启示
Med J Aust. 1989 Aug 7;151(3):120-2. doi: 10.5694/j.1326-5377.1989.tb139593.x.
6
Absorption and elimination of bismuth from oral doses of tripotassium dicitrato bismuthate.口服三钾二枸橼酸铋盐后铋的吸收与消除
Eur J Clin Pharmacol. 1989;37(5):533-6. doi: 10.1007/BF00558139.
7
The absorption of bismuth from oral doses of tripotassium dicitrato bismuthate.口服三枸橼酸铋钾后铋的吸收情况。
Aliment Pharmacol Ther. 1989 Feb;3(1):29-39. doi: 10.1111/j.1365-2036.1989.tb00188.x.
8
Campylobacter pyloridis gastritis II: Distribution of bacteria and associated inflammation in the gastroduodenal environment.幽门弯曲菌性胃炎II：细菌在胃十二指肠环境中的分布及相关炎症
Am J Gastroenterol. 1987 Apr;82(4):297-301.
9
Trends in the incidence and transmission patterns of trichinosis in humans in the United States: comparisons of the periods 1975-1981 and 1982-1986.美国人类旋毛虫病的发病率和传播模式趋势：1975 - 1981年和1982 - 1986年期间的比较
Rev Infect Dis. 1990 Jan-Feb;12(1):5-11. doi: 10.1093/clinids/12.1.5.
10
Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis.幽门螺杆菌相关性慢性胃炎中的细菌黏附与疾病活动
Gut. 1990 Feb;31(2):134-8. doi: 10.1136/gut.31.2.134.
Zotero 插件